ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 117 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $93,000 | -66.3% | 17,561 | -69.5% | 0.00% | -100.0% |
| Q1 2021 | $276,000 | +60.5% | 57,484 | +44.4% | 0.00% | +100.0% |
| Q4 2020 | $172,000 | -49.3% | 39,822 | -51.7% | 0.00% | -80.0% |
| Q3 2020 | $339,000 | +1203.8% | 82,363 | +721.4% | 0.01% | – |
| Q2 2020 | $26,000 | -77.2% | 10,027 | -66.8% | 0.00% | -100.0% |
| Q4 2019 | $114,000 | -7.3% | 30,177 | +52.4% | 0.00% | 0.0% |
| Q2 2019 | $123,000 | -41.7% | 19,803 | -19.9% | 0.00% | -50.0% |
| Q4 2018 | $211,000 | -79.9% | 24,720 | -52.8% | 0.00% | -84.6% |
| Q3 2018 | $1,049,000 | -68.7% | 52,400 | -59.7% | 0.01% | -70.5% |
| Q2 2018 | $3,355,000 | +301.3% | 129,874 | +271.2% | 0.04% | +238.5% |
| Q1 2018 | $836,000 | +8.0% | 34,992 | +53.3% | 0.01% | 0.0% |
| Q4 2017 | $774,000 | +223.8% | 22,828 | +102.1% | 0.01% | +160.0% |
| Q3 2017 | $239,000 | – | 11,296 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 808,431 | $3,501,000 | 2.68% |
| AIGH Capital Management LLC | 875,851 | $3,793,000 | 1.54% |
| Healthcare Value Capital, LLC | 100,000 | $433,000 | 1.46% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 440,955 | $1,909,000 | 1.11% |
| Opaleye Management Inc. | 1,487,800 | $6,442,000 | 0.84% |
| Worth Venture Partners, LLC | 225,106 | $975,000 | 0.77% |
| ARMISTICE CAPITAL, LLC | 2,742,000 | $11,873,000 | 0.40% |
| DELTEC ASSET MANAGEMENT LLC | 245,399 | $1,063,000 | 0.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 278,011 | $1,204,000 | 0.15% |
| Mosaic Family Wealth, LLC | 91,807 | $398,000 | 0.13% |